De novo daptomycin-nonsusceptible enterococcal infections

Area of Science:

• Infectious Diseases
• Microbiology
• Antimicrobial Resistance

Background:

• Enterococci are a common cause of hospital-acquired infections.
• Daptomycin is a critical antibiotic for treating serious enterococcal infections.
• Nonsusceptibility to daptomycin in enterococci is an emerging clinical challenge.

Purpose of the Study:

• To investigate the mechanisms behind the emergence of daptomycin nonsusceptibility in enterococci.
• To understand the clinical and public health implications of daptomycin-nonsusceptible enterococci in patients without prior daptomycin exposure.

Main Methods:

• Analysis of clinical data from patients with enterococcal infections.
• Molecular typing to assess the genetic relatedness of daptomycin-nonsusceptible enterococcal isolates.
• Investigation of potential sporadic emergence and clonal spread.

Main Results:

• Daptomycin nonsusceptibility can emerge in enterococci even in patients with no history of daptomycin use.
• Both sporadic emergence (e.g., through new mutations) and clonal spread contribute to the dissemination of these resistant strains.
• This highlights a significant challenge in managing enterococcal infections.

Conclusions:

• The emergence of daptomycin-nonsusceptible enterococci is a complex issue involving multiple mechanisms.
• Clinical vigilance and infection control strategies are crucial to mitigate the spread of resistant strains.
• Further research is needed to understand and combat this evolving public health threat.